Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Paz-Ares

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2018
Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitorsD Westover, J Zugazagoitia, B C Cho, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 23, 2013
Proteomic biomarkers in lung cancerM D Pastor, A Nogal, S Molina-Pinelo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2003
Progress in the development and acquisition of anticancer agents from marine sourcesM L Amador, J Jimeno, L Paz-Ares, et al.
Archivos De Bronconeumologia|March 21, 2006
[Multimodal treatment of clinical non-small cell N2 bronchogenic carcinoma. What is the answer?]A López-Encuentra, J L Martín de Nicolás, L Paz-Ares, et al.
Revista Clinica Espanola|July 1, 1997
[Long-term course of blood lipids and body mass index in patients with testicular cancer treated with chemotherapy]C Fernández-Miranda, N Schoebel, A Angulo, et al.
Cancer|August 5, 1998
Favorable prognosis after late relapse of Hodgkin's diseaseR Garcia-Carbonero, L Paz-Ares, A Arcediano, et al.
Archivos Espanoles De Urologia|September 26, 2000
[Diagnosis and management of carcinoma in situ of the testis]V Valentí Moreno, J Tabernero Caturla, H Villavicencio Mavrich, et al.
The Journal of Urology|May 7, 2002
Primary cisplatin, methotrexate and vinblastine chemotherapy with selective bladder preservation for muscle invasive carcinoma of the bladder: long-term followup of a prospective studyF de la Rosa, R Garcia-Carbonero, J Passas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 20, 2009
SEOM guidelines for the management of non-small-cell lung cancer (NSCLC)E Felip, P Garrido, J M Trigo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 30, 2013
Lung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkersE Conde, B Angulo, E Izquierdo, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2018
Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitorsD Westover, J Zugazagoitia, B C Cho, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 23, 2013
Proteomic biomarkers in lung cancerM D Pastor, A Nogal, S Molina-Pinelo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2003
Progress in the development and acquisition of anticancer agents from marine sourcesM L Amador, J Jimeno, L Paz-Ares, et al.
Archivos De Bronconeumologia|March 21, 2006
[Multimodal treatment of clinical non-small cell N2 bronchogenic carcinoma. What is the answer?]A López-Encuentra, J L Martín de Nicolás, L Paz-Ares, et al.
Revista Clinica Espanola|July 1, 1997
[Long-term course of blood lipids and body mass index in patients with testicular cancer treated with chemotherapy]C Fernández-Miranda, N Schoebel, A Angulo, et al.
Cancer|August 5, 1998
Favorable prognosis after late relapse of Hodgkin's diseaseR Garcia-Carbonero, L Paz-Ares, A Arcediano, et al.
Archivos Espanoles De Urologia|September 26, 2000
[Diagnosis and management of carcinoma in situ of the testis]V Valentí Moreno, J Tabernero Caturla, H Villavicencio Mavrich, et al.
The Journal of Urology|May 7, 2002
Primary cisplatin, methotrexate and vinblastine chemotherapy with selective bladder preservation for muscle invasive carcinoma of the bladder: long-term followup of a prospective studyF de la Rosa, R Garcia-Carbonero, J Passas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 20, 2009
SEOM guidelines for the management of non-small-cell lung cancer (NSCLC)E Felip, P Garrido, J M Trigo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 30, 2013
Lung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkersE Conde, B Angulo, E Izquierdo, et al.
Pageof 10